… insulin-like growth factor I (IGF-I) on growth of small cell lung cancer (SCLC) cell lines was
… Growth factor effects on small cell lung cancer cells using a colorimetric assay: can a transfer…

… , and by disruption of associated membrane growth factor receptor signaling. The results …
leading to modulation of the growth and survival of breast and non-small cell lung cancers. …

… factors for response to another class of targeted therapies in lung cancer, epidermal
growth factor receptor inhibitors, have been extensively reported (7), no predictive factors for …

… growth factor receptor gene were associated with clinical responses to erlotinib and gefitinib
in patients with non–small cell lung cancer. … with non–small cell lung cancer. Although a …

… II, IIIA, IIIB, and IV non–small-cell lung cancer patients. Each patient received one of three
doses (1.25, 2.5, or 5.0 × 10 7 cells/injection) of belagenpumatucel-L on a monthly or every …

… Epidermal growth factor receptor (EGFR) gene mutations and increased copy numbers are
… ) in non-small-cell lung cancer (NSCLC). Lung cancer diagnosis is often based on cytology …

… growth factor alpha (TGF alpha), amphiregulin (AR), CRIPTO, the epidermal growth factor
receptor (EGFR), erbB-2, erbB-3, and tumor … I-IIIA non-small cell lung cancer (NSCLC) treated …

… growth factor receptor (EGFR) pathway can prolong survival in patients with non–small cell
lung cancer … In the Iressa Survival Evaluation in Lung Cancer trial, no significant prolongation …

… of lung cancer cells expressing mutant EGFRs. We next determined whether STAT3 plays
a role in the growth and survival of lung cancer cells with mutant EGFRs. HCC-827 cells were …

… hallmarks of cancer. The insulin-like growth factor (IGF) signaling system is one such
pathway, and plays a key role in the growth and development of non-small cell lung cancer (NSCLC…